Update your tester profile Login
  • *NEW INFO* Change in Prism's Entrance for Screenings

    University Enterprise Laboratories is currently undergoing construction on the south side of the building. 

    The south entrance will be closed starting Wednesday, July 18th2018 until further notice. 

    FOR SCREENINGS: Please enter through the East entrance (closest side to Hwy 280). In order to get inside, please pick up the phone in the weather proof box. This will ring to the nurses station and a staff member will be able to let you in. 

    Please tell them you are here for a screening appointment (if you know the study number even better!). 

    If you pick up the phone and it doesn't have a dial tone, remain on the line until someone answers (it will still ring in the nurses station). 

    If no one answers the phone please knock twice and then try calling again.

     

    Thank you for your patience during the construction. 

    Prism Staff 

  • Register with Our Database

    Get started on the volunteer process by registering your basic information with our database. This information is provided to help us determine your eligibility for current and future studies.

    If you have registered with Prism in the past, please call Dayna 651-724-5047 to update your profile or learn about available studies. 


    Thanks for your interest, you'll find the intake form here

     Unfortunately at this time, Prism can not allow volunteers who live over 200 miles away to participate in research studies. If you live out of state or over 200 miles away please call Geoff at 651-641-2911 with questions. 

    We will not share or sell this info with any third party.

  • Connect With Prism Research on Social Media

    You can WIN TICKETS VIA Prism's Facebook page!

    Have you LIKED Prism Clinical Research on Facebook?

    Have you TAGGED Prism Clinical Research on Twitter?

    Have you FOLLOWED Prism Clinical Research on Instagram?

     

    Use the link below:↓

    https://www.facebook.com/PrismResearch/

  • Refer Your Friends & Family to Participate

    Simply help us get the word out about Prism Clinical Research and we’ll give you $100 for every friend you refer that completes a study.

    It’s that easy! Make money with each referral, and there’s no limit to how many friends you can refer!

    Rules:

    • Subject must qualify for a study.
    • Subject may not be referred more than one time.
    • Subjects eligible for Referral: (1) Must not be in Prism Clinical Research database; (2) Must not have participated in any prior study at Prism.
    • In the event that a subject is referred by multiple people, the first person who referred will receive payment.
    • Eligibility will be determined by Prism. Prism reserves the right to revise or eliminate this program at any time without notice.

     

     

  • Let's Talk About Endometriosis

    Prism Research has upcoming studies for individuals diagnosed with moderate to severe Endometriosis.  These studies will help determine how an investigational drug is broken down and removed from the body.

     If you or someone you know has been diagnosed with endometriosis and are interested in being considered for these studies, please contact Dayna at 651-724-5047 or register with our database and we will call you. Financial compensation for study participation ranges from $225-$2600.

    Let's Talk 

    Please contact Dayna at 651-724-5047 or daynas@prismresearchinc.com

     

     

  • Diagnosed with Celiac Disease?

    Prism Research has upcoming studies for individuals who have been diagnosed with Celiac Disease.  These FDA approved studies will help determine how an investigational drug being developed for Celiac Disease is broken down and removed from the body in volunteers diagnosed with Celiac Disease.

    If you or someone you know has been diagnosed with Celiac Disease and are interested in being considered for these studies, please contact Dayna at 651-724-5047 or register with our database and we will call you. Participants who qualify will receive a no cost health evaluation in addition to financial compensation for study participation time.

    Please contact Dayna at 651-724-5047 or daynas@prismresearchinc.com for more information on these upcoming studies for individuals diagnosed with Celiac Disease. 

    Study 1803 Part B

    Cour Pharmeceuticals New Drug

    Recruiter: 651-724-5047

     

  • Diagnosed with Liver Impairment?

    Prism Research has upcoming studies for individuals diagnosed with liver impairment.  These studies will help determine how an investigational drug is broken down and removed from the body in volunteers with various degrees of liver impairment when compared to volunteers with normal liver function.

     If you or someone you know has been diagnosed with liver impairment and are interested in being considered for these studies, please contact Dayna at 651-724-5047 or register with our database and we will call you. Financial compensation for study participation ranges from $400-$3500.

    Please contact Dayna at 651-724-5047 or daynas@prismresearchinc.com

    Current Studies: 1810, 1813 & 1817

  • Diagnosed with Kidney Impairment?

    Prism Research has upcoming studies for individuals diagnosed with kidney impairment.  These studies will help determine how an investigational drug is broken down and removed from the body in volunteers with various degrees of kidney impairment when compared to volunteers with normal kidney function.

     If you or someone you know has been diagnosed with kidney impairment and are interested in being considered for these studies, please contact Lindsay at 651-368-3360 or register with our database and we will call you. Financial compensation for study participation ranges from $400-$3500.

    Please contact Lindsay at 651-368-3360 or lindsayd@prismresearchinc.com

  • Celiac Disease: 1803 Part B

    Celiac Disease Study

    CLINICAL RESEARCH STUDY: 1803 Part B

    PRISM CLINICAL RESEARCH

    Purpose:

    • To evaluate an investigational drug being developed for the treatment of Celiac Disease.

     

    GENERAL STUDY REQUIREMENTS:

    • Men and Women who are willing to use an acceptable form of birth control, between the ages of 18 to 75 with a BMI between 18.0 -25.0 kg/m2.
    • Diagnosed by biopsy with Celiac Disease
    • No known gluten exposure for at least 10 days prior to screening visit

     

    STUDY DURATION:

    • In Clinic Stay: 2 Clinical stays of 3 nights/4 days.
    • Clinic Visits: approximately 5 to 6 including screening.
    • Phone Calls: approximately 9-10 phone follow ups.
    • Total study duration is approximately 7 months.

     

    METHOD OF ADMINISTRATION:

    Intravenous Administration

     

    STUDY COMPENSATION:

      • Compensation for Study Participation Time Up To: $2,825.00

     

    RECRUITMENT CONTACT:

    Dayna 651-724-5047 or daynas@prismresearchinc.com

     

  • Asthma: Clinical Research Study 1804

    PURPOSE:

    * To evaluate the safety and tolerability of an investigational drug in individuals diagnosed with persistent asthma who are being treated and are on a stable asthma therapy.

     

    GENERAL STUDY REQUIREMENTS:

    *Men and Women Between The age of 18 and 65

    * Individuals with Asthma on a stable Asthma Therapy

     

    STUDY DURATION:

    * 3 In-Clinic Stays: Each Lasting 4 nights/5 days

    * Return Clinic Visits: 10, Including Screening

    * Total Study Duration is Approximately 35 Weeks

     

    METHOD OF ADMINISTRATION:

    * Subcutaneous Dosing

     

    STUDY COMPENSATION:

    * Compensation for Study Participation may be granted for time and travel

     

    RECRUITMENTCONTACT:

    *  Dayna 651-724-5047 or daynas@prismresearchinc.com

  • Dialysis: Clinical Research Study 1809

    Study for Hemodialysis Patients

    Clinical RESEARCH study: 1809 (DS2330-A-U103)

     

    PRISM clinical RESEARCH

     

    Purpose:

    •  To evaluate the safety and tolerability of an investigational drug in individuals on hemodialysis and in combination with a known FDA approved medication, sevelamer.

     

    GENERAL STUDY REQUIREMENTS:

    •  Men and Women between the age of 18 and 80 with a body mass index (BMI) between 18kg/m²and 40kg/m².
    •  Volunteers must be on hemodialysis for the past 3 months

     

    STUDY DURATION:

    •  In Clinic Stay: 15 nights/16 days.
    •  Return Clinic Visits:  Up to 8, including screening.
    •  Total study duration is approximately 10.5 weeks (including a 29 day screening period).

     

    METHOD OF ADMINISTRATION:

     Oral Administration

     

    STUDY COMPENSATION:

    •  Compensation for Study Participation Time Up To: $5,195.00

     

    RECRUITMENT CONTACT:

     

     

     

     

  • Liver Impairment: Clinical Research Study 1810

     

     Hepatic Study

    CLINICAL RESEARCH STUDY: 1810

    PRISM CLINICAL RESEARCH

     

     

    PURPOSE:

    •  To evaluate the absorption/elimination rate and safety/tolerability of an investigational drug being developed for the treatment of type 2 diabetes mellitus.

     

    GENERAL STUDY REQUIREMENTS:

    •  Men and Women Between the ages of 18 and 75 years old
    •  Hepatic volunteers: must be diagnosed with moderate liver disease.
    •  Healthy volunteers: must be healthy; not being evaluated or treated for any medical conditions.

     

    STUDY DURATION:

    •  1 In-Clinic Stay: Lasting 4 nights/ 5 days
    •  1 Follow Up Phone Call
    •  Total Study Duration is Approximately 2 Months

     

    METHOD OF ADMINISTRATION:

    •  Oral Administration

     

    STUDY COMPENSATION:

    •  Compensation for Study Participation may be granted for time and travel up to $1295.00

     

    RECRUITMENT CONTACT:

     

     

     

     

  • Kidney Impairment: Clinical Research Study 1812

    Renal Impairment Study

    Clinical RESEARCH study: 1812

     

    PRISM Clinical RESEARCH

     

     

     

     

    Purpose:

    •  A research study to evaluate the safety and tolerability of an investigational drug in individuals with renal impairment compared with individuals without renal impairment.

     

    GENERAL STUDY REQUIREMENTS:

    •  Men and Women Who are not able to become pregnant, between the ages of 18 to 75 with a BMI between 17.5 and 36 kg/m2.
    •  Medical conditions and medications must be stable in the opinion of the study doctor.

     

    STUDY DURATION:

    •  In Clinic Stay: 6 nights/7 days.
    •  Clinic Visits: up to 3 including screening and possible Follow-up visit.
    •  Total study duration is approximately 6 weeks (including a 14-day screening period).

     

    METHOD OF ADMINISTRATION:

    •  Oral Administration

     

    STUDY COMPENSATION:

    •  Compensation for Study Participation Time Up To: $2,385.00

     

    RECRUITMENT CONTACT:

     

     

  • Liver Impairment: Clinical Research Study 1813

    Abnormal Liver Function Study

    CLINICAL RESEARCH STUDY: 1813

    PRISM CLINICAL RESEARCH

    PURPOSE:

    To determine how the investigational drug is absorbed, broken down, and removed from the body in volunteers with abnormal liver function compared to volunteers with normal liver function.

     

    GENERAL STUDY REQUIREMENTS:

    • Men and Women Between the ages of 18 and 70 years old.
    • Abnormal liver function volunteers: must have mild/moderate abnormal liver function due to diagnosed liver disease.
    • Healthy volunteers: must be healthy; not being evaluated or treated for any medical conditions.

     

    STUDY DURATION:

    • 1 In-Clinic Stay: Lasting 4 nights/ 5 days
    • Up to 2 clinic visits for Screening
    • 1 Follow Up Phone Call or clinic visit
    • Total Study Duration is Approximately 64 days, including screening

     

    METHOD OF ADMINISTRATION:

    • Oral Administration

     

    STUDY COMPENSATION:

    • Compensation for Study Participation may be provided for time and travel up to $1785.00

     

    RECRUITMENT CONTACT:

     

     

     

     

     

  • Kidney Impairment: Clinical Research Study 1816

     #18300142.0

     

    Renal Impairment Study

    Clinical RESEARCH study: 1816

     

    PRISM CLINICAL RESEARCH

      

    Purpose:

    •  To evaluate the safety and tolerability of an investigational drug in individuals with renal impairment.

     

    GENERAL STUDY REQUIREMENTS:

    • Men and Women, between the ages of 30 and 80
    • Medical conditions and medications must be stable in the opinion of the study doctor.
    • Volunteers must agree to use contraception, if applicable

     

    STUDY DURATION:

    • In Clinic Stay: 4 in clinic stays of 48 hours each.
    • Clinic Visits: 7, including screening.
    • Telephone Visit: 1.
    • Total study duration is approximately 14 weeks (including a 28-day screening period).

     

    METHOD OF ADMINISTRATION:

    • Oral administration

     

    STUDY COMPENSATION:

    •  Compensation for Study Participation Time Up To: $3525.00

     

    RECRUITMENT CONTACT:

  • Liver Impairment: Clinical Research Study 1817

    LIVER IMPAIRMENT STUDY

    CLINICAL RESEARCH STUDY: 1817

    PRISM CLINICAL RESEARCH

    PURPOSE:

    • To determine how the investigational drug is absorbed, broken down, and removed from the body in volunteers with abnormal liver function compared to volunteers with normal liver function.

     

    GENERAL STUDY REQUIREMENTS:

    • Men and women between the ages of 18 and 80 years old.
    • Liver Impairment volunteers: must have mild/moderate/severe liver impairment due to diagnosed liver disease.
    • Healthy volunteers: must be healthy; not being evaluated or treated for any medical conditions.

     

    STUDY DURATION:

    • 1 In-Clinic Stay: Lasting 8 nights/ 9 days
    • Clinic Visits: 1(screening)
    • Total Study Duration is Approximately 39 days, including screening

     

    METHOD OF ADMINISTRATION:

    • Oral Administration

     

    STUDY COMPENSATION:

    • Compensation for Study Participation may be provided for time and travel up to $2620.00

     

    RECRUITMENT CONTACT:

  • Upcoming Studies

     

     

     Prism has a variety of upcoming studies to participate in: 

    • Studies for healthy males and females 
    • Liver Impairment 
    • Kidney Impairment 
    • Diabetes

    To be put on the call list and receive more information, when available, please contact Dayna at daynas@prismresearchinc.com or Lindsay at lindsayd@prismresearchinc.com.

The Enrollment Process

Most people who are interested in volunteering for a clinical trial have many questions. This page is designed to answer the most common questions our recruitment team receives from volunteers. Please do not hesitate to contact a recruiter by phone or email if you would like additional information or have a question that is not addressed on this page. We want to ensure that you are well informed before you agree to volunteer for a trial and we are happy to answer any questions you might have.


Icon 35    Step 1: Phone Interview

Arrange a phone interview and one of our recruiters will determine if you are an eligible candidate. The Phone Screen is a conversation between you, as a potential volunteer, and a recruiter. It is the first required step in participating in a clinical trial. and you should set aside about 45 minutes to an hour. Your recruiter will ask you a series of general questions concerning your contact information, height and weight, age, race and personal health history. By collecting this information, your recruiter will determine if you might fit the criteria for any upcoming studies. Many of the phone screen questions can be answered online.  Doing so will notify our recruitment team that you are interested in studies, will register you for study updates and will also speed up the phone screen process. Once you complete your online portion, a recruiter will call you to complete the phone screen.

Once your information has been added into the database, either by you via download or by speaking with a recruiter, your recruiter will then discuss the details of any studies you might qualify for. The recruiter will explain the time commitment, specific dates, research purpose and compensation of the trials.

If you are interested in participating in a suggested trial, your recruiter must then make certain that you are not disqualified from that trial due to any exclusion criteria. You will be asked another series of questions that specifically relate to the study you are volunteering for. The exclusion criteria are established by the study sponsor in order to ensure the safety of volunteers and the accuracy of data collected.

Icon 13    Step 2: Informed Consent

Signing Informed Consent and undergoing your Physical Screen will happen during the same visit to our facility. Expect the visit to take approximately 2.5 hours. Volunteers are required to provide a photo ID at the time of the Physical Screen. If their photo ID does not list a current address, volunteers must provide additional documentation of their address such as a utility or cable bill. It is mandatory that all potential volunteers review the Informed Consent Form. This is regarded as the most important process in clinical trials. The Informed Consent Form is a document that details all aspects of the research study, the potential risks involved and what happens during the entire study. It is approved by an ethics and safety committee called the Institutional/Independent Review Board (IRB). No studyrelated procedures or requirements can begin until volunteers understand and sign the specific, studyrelated Informed Consent Form. 

Volunteers receive a copy of the Informed Consent Form. You will be required to sign the Informed Consent Form if you are interested in continuing the enrollment process. The Informed Consent Form does not legally obligate you to participate in the trial. It also does not guarantee you a position in the trial. It is a document designed to protect your rights as a volunteer; it confirms you have been given information concerning all aspects of the trial and that you understand what will take place during the trial.

We are committed to a transparent, trusting and open relationship with our volunteers. 

Icon 51    Step 3: Physical Screen

Each trial requires a different series of procedures as part of the Physical Screen. Common procedures include: blood draws, heart monitoring, vital signs, body measurements, urine samples, and drug tests.

You will meet with a doctor or Physician Assistant at the time of your Physical Screen. He or she will perform a brief physical examination and discuss your personal health history. Volunteers are strongly encouraged to ask him/her any questions you might have concerning the study. 

All trials require a minimum of one Physical Screen, however; some studies require multiple screening appointments. Some studies also require hearing or eye exams which take place at clinics working in conjunction with Prism. Your recruiter will outline the screening schedule at the time of your Phone Screen.

Once all of your lab work has been completed and reviewed, a Prism staff member will call to notify you of your enrollment status. If your lab results meet the requirements for the study, the staff member will confirm your enrollment and give you admit instructions.

Icon 40    Step 4: Your Study

Once your study has been scheduled, you can make preparations for your visit. Each study is different – some require a series of visits and keeping a home diary, some require you to remain at the clinic for several hours or days, depending on the drug and the effects being studied. You will have a clear and complete understanding of your study before you arrive. You will be informed about what to bring with you, where to report, and what will be necessary for a successful trial.

Our first priority is that you understand and are comfortable with our process every step of the way

Please provide us with your contact information (below) and will get back to you as soon as possible.

If you have a general question, check Volunteer FAQ for an answer. If you're unsure of who to contact, please visit the Contact Us page.

Cancel